In OC, dysregulation of ALKBH5 and FTO takes part in proliferation, apoptosis, migration, drug resistance, cancer stem cell development and tumour autophagy, contributing to the relapse of OC patients [39, 77–79, 95] (Table 2). This evidence concerns the gene ALKBH5 and cancer.